abstract |
(57) Abstract: A formula (I) which is a vitronectin receptor antagonist and is useful for treating osteoporosis. Wherein A is CH 2 or O; R 1 is H, halogen or C 1-6 alkyl; R 2 is H, C 1-6 alkyl or CH 2 NR “R”; O or CH 2 ; Y is (a), (b), (c), (d), (e), (f) or (g); G is NR ", S, or O; R 'is H, C 1-6 alkyl, OC 1-6 alkyl, SC 1-6 alkyl, NR""be or halogen; R" R are each independently And H is C 1-6 alkyl; s represents 0, 1 or 2], or a pharmaceutically acceptable salt thereof. |